Assessment of Pain in People With Thalassemia Who Are Treated With Regular Blood Transfusions

Trial ID or NCT#

NCT00872833

Status

not recruiting iconNOT RECRUITING

Purpose

Thalassemia is an inherited blood disorder that can result in mild to severe anemia. Regular blood transfusions, which refresh the healthy red blood cell supply, are one treatment for thalassemia. People with thalassemia often experience pain, but the exact source of pain remains unknown. This study will examine how pain varies during the blood transfusion cycle in people with thalassemia who are treated with regular blood transfusions.

Official Title

Assessment of Pain in Transfusion Dependent Patients With Thalassemia During Transfusion Cycles

Eligibility Criteria

Ages Eligible for Study: Older than 18 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. - Participating in the Thalassemia Clinical Research Network Assessment of Pain study - Has a transfusion dependence of at least eight transfusions per year - Diagnosis of beta thalassemia or E-beta-thalassemia - Experiences at least "mild" pain in the 1 month before study entry, as measured by the response to the Brief Pain Inventory (BPI) question #6 from the Assessment of Pain study
Exclusion Criteria:
  1. - Unwillingness or inability to complete the Brief Pain Inventory Short Form (BPI-SF) on a daily basis
View All Criteria
Show Less

Investigator(s)

Maurice L. Druzin
Maurice L. Druzin
Obstetrician and Gynecologist (OB-GYN)
Professor of Obstetrics and Gynecology (Maternal Fetal Medicine) and, by courtesy, of Pediatrics

View on ClinicalTrials.gov